Moleculin Biotech (MBRX) Buys Active Drug Compound for Treatment of Brain Cancer
Go back to Moleculin Biotech (MBRX) Buys Active Drug Compound for Treatment of Brain Cancer| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 4.30 -0.35 (7.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.65 | 52 Week High | $9.58 | |||
| Open | $4.78 | 52 Week Low | $2.34 | |||
| Day High | $4.78 | P/E | N/A | |||
| Day Low | $4.30 | EPS | $-0.34 | |||
| Volume | 16,771 | |||||
